Rho GTPase-Activating Protein Deleted in Liver Cancer Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma
| Autor: | Meenakshi B. Bhattacharjee, Robert C. Dauser, Laszlo Perlaky, Yi Mieng Chang, Yvonne T.M. Tsang, Jack Su, Adekunle M. Adesina, Ching C. Lau, Kwong Kwok Wong, Dawna L. Armstrong, Susan M. Blaney, Murali Chintagumpala |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
rho GTP-Binding Proteins
Cancer Research Carcinoma Hepatocellular Tumor suppressor gene GTPase-activating protein Mice Nude Cell Growth Processes Biology Mice Cell Movement Cell Line Tumor Cell Adhesion medicine Animals Humans Genes Tumor Suppressor Neoplasm Invasiveness Regulation of gene expression Genetics Mice Inbred BALB C Cell growth Tumor Suppressor Proteins GTPase-Activating Proteins Liver Neoplasms medicine.disease Candidate Tumor Suppressor Gene Enzyme Activation Oncology Hepatocellular carcinoma Cancer cell Mutagenesis Site-Directed Cancer research Female DLC1 |
| Zdroj: | Cancer Research. 65:8861-8868 |
| ISSN: | 1538-7445 0008-5472 |
| DOI: | 10.1158/0008-5472.can-05-1318 |
| Popis: | Deleted in liver cancer (DLC1) is a candidate tumor suppressor gene recently isolated from human hepatocellular carcinoma. Structurally, DLC1 protein contains a conserved GTPase-activating protein for Rho family protein (RhoGAP) domain, which has been thought to regulate the activity of Rho family proteins. Previous studies indicated that DLC1 was frequently inactivated in cancer cells. In the present study, we aimed to characterize the tumor suppressor roles of DLC1 in hepatocellular carcinoma. We showed that DLC1 significantly inhibited cell proliferation, anchorage-independent growth, and in vivo tumorigenicity when stably expressed in hepatocellular carcinoma cells. Moreover, DLC1 expression greatly reduced the motility and invasiveness of hepatocellular carcinoma cells. With RhoGAP-deficient DLC1 mutant (DLC1-K714E), we showed that the RhoGAP activity was essential for DLC1-mediated tumor suppressor function. Furthermore, the 292– to 648–amino acid region and the steroidogenic acute regulatory related lipid transfer domain played an auxiliary role to RhoGAP and tumor suppressor function of DLC1. Taken together, our findings showed that DLC1 functions as a tumor suppressor in hepatocellular carcinoma and provide the first evidence to support the hypothesis that DLC1 suppresses cancer cell growth by negatively regulating the activity of Rho proteins. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|